Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing escitalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Escitalopram 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram (as escitalopram oxalate) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram (as escitalopram oxalate) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram oxalate |
Is a |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram (as escitalopram oxalate) 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram (as escitalopram oxalate) 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escitalopram (as escitalopram oxalate) 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Escitalopram (as escitalopram oxalate) 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Escitalopram (as escitalopram oxalate) 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Escitalopram oxalate |
Is modification of (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing escitalopram in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only escitalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only escitalopram in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Escitalopram (as escitalopram oxalate) 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clonazepam- and escitalopram-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only clonazepam and escitalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only clonazepam and escitalopram in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clonazepam- and escitalopram-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clonazepam 500 microgram and escitalopram (as escitalopram oxalate) 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Escitalopram (as escitalopram oxalate) 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Escitalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |